Transparency is often a word…
Transparency is often a word pharma companies like to use, [...]
Two ex-Moderna leaders have hit a…
Two ex-Moderna leaders have hit a milestone in their new [...]
Expedition Therapeutics is gearing…
Expedition Therapeutics is gearing up for a phase 2 trek [...]
Ono Pharmaceutical’s EP4…
Ono Pharmaceutical’s EP4 antagonist hit the primary progression-free survival endpoint [...]
After axing a vast array of…
After axing a vast array of federal research projects and [...]
Arthrosi Therapeutics has raised…
Arthrosi Therapeutics has raised $153 million to bankroll its bid [...]
In a pair of deals, TransCode has…
In a pair of deals, TransCode has bagged a phase [...]
Six months after his departure…
Six months after his departure from the federal government, Peter [...]
The financing will help Kernal…
The financing will help Kernal advance its early-stage program KR-402 [...]
A new RNA biotech has risen with a…
A new RNA biotech has risen with a $200 million [...]